Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

Summary

The purpose of this study is to evaluate the effects of continuous simvastatin administration on the hepatic venous pressure gradient (HVPG), as a surrogate marker of prognosis, and its safety in patients with cirrhosis and portal hypertension.

Timeline

Start

2004-03

Primary completion

2007-04

Completion

2007-11

Drugs

Indications